HRMY Q1 2025 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$185M+19.5% YoY

Gross Profit

$153M82.7% margin

Operating Income

$56M30.4% margin

Net Income

$46M24.7% margin

EPS (Diluted)

$0.78

QoQ Revenue Growth

-8.2%

Cash Flow

Operating Cash Flow

$34M

Free Cash Flow

$34M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$335M

Stockholders' Equity

$721M

Cash & Equivalents

$489M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$185M	$155M	+19.5%
Gross Profit	$153M	$127M	+20.1%
Operating Income	$56M	$52M	+8.1%
Net Income	$46M	$38M	+18.9%